Adapti, Inc.
ADTISync financial data to generate a health grade for this company.
Analytical Summary
Review the statement evidence below to form a view on ADTI.
8-Year Financial Trajectory
QuarterlyStatement lens
Choose the reporting cadence, isolate a period range, or search directly for a metric.
| Metric | Q3 FY2026 Dec 31, 2025 10-Q ↗ | Q2 FY2026 Sep 30, 2025 10-Q ↗ | Q1 FY2026 Jun 30, 2025 10-Q ↗ | Q4 FY2025 Mar 31, 2025 10-Q ↗ | Q3 FY2025 Dec 31, 2024 10-Q ↗ | Q2 FY2025 Sep 30, 2024 10-Q ↗ | Q1 FY2025 Jun 30, 2024 10-Q ↗ | Q4 FY2024 Mar 31, 2024 10-Q ↗ |
|---|---|---|---|---|---|---|---|---|
| Revenue Growth YoY (%) |
122544.3%
Excellent
Excellent
Year-over-year change in total revenue
Optimal:
> 10%
vs Sector:
Above avg (+2450786%)
|
104896.9%
Excellent
Excellent
Year-over-year change in total revenue
Optimal:
> 10%
vs Sector:
Above avg (+2097838%)
|
— | — | — | — | — | — |
| EPS Growth YoY (%) |
-94.7%
Weak
Weak
Year-over-year change in earnings per share
Optimal:
> 10%
|
-180.0%
Weak
Weak
Year-over-year change in earnings per share
Optimal:
> 10%
|
— | — | — | — | — | — |
| Net Income Growth YoY (%) |
-933.5%
Weak
Weak
Year-over-year change in net income |
-5.8%
Weak
Weak
Year-over-year change in net income |
— | — | — | — | — | — |
| FCF Growth YoY (%) |
-148.7%
Weak
Weak
Year-over-year change in free cash flow |
— | — | — | — | — | — | — |
| Metric | Q3 FY2026 Dec 31, 2025 10-Q ↗ | Q2 FY2026 Sep 30, 2025 10-Q ↗ | Q1 FY2026 Jun 30, 2025 10-Q ↗ | Q4 FY2025 Mar 31, 2025 10-Q ↗ | Q3 FY2025 Dec 31, 2024 10-Q ↗ | Q2 FY2025 Sep 30, 2024 10-Q ↗ | Q1 FY2025 Jun 30, 2024 10-Q ↗ | Q4 FY2024 Mar 31, 2024 10-Q ↗ |
|---|---|---|---|---|---|---|---|---|
| Operating Margin (%) (%) |
-178.7%
Weak
Weak
Operating income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-1589%)
|
-113.2%
Weak
Weak
Operating income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-1043%)
|
— | — | — | — | — | — |
| Profit Margin (%) (%) |
-193.1%
Weak
Weak
Net income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-2514%)
|
-13.8%
Weak
Weak
Net income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-273%)
|
— | — | — | — | — | — |
| FCF Margin (%) (%) |
-50.2%
Weak
Weak
Free cash flow as a percentage of revenue
Optimal:
> 10%
|
— | — | — | — | — | — | — |
| FCF / Net Income (x) |
0.26x
Weak
Weak
Free cash flow relative to reported net income
Optimal:
> 1x
|
— | — | — |
0.20x
Weak
Weak
Free cash flow relative to reported net income
Optimal:
> 1x
|
— | — | — |
| Metric | Q3 FY2026 Dec 31, 2025 10-Q ↗ | Q2 FY2026 Sep 30, 2025 10-Q ↗ | Q1 FY2026 Jun 30, 2025 10-Q ↗ | Q4 FY2025 Mar 31, 2025 10-Q ↗ | Q3 FY2025 Dec 31, 2024 10-Q ↗ | Q2 FY2025 Sep 30, 2024 10-Q ↗ | Q1 FY2025 Jun 30, 2024 10-Q ↗ | Q4 FY2024 Mar 31, 2024 10-Q ↗ |
|---|---|---|---|---|---|---|---|---|
| Return on Invested Capital (%) |
-16.0%
Weak
Weak
Return earned on debt + equity capital invested
Optimal:
> 10%
|
-11.9%
Weak
Weak
Return earned on debt + equity capital invested
Optimal:
> 10%
|
— | — |
19.6%
Excellent
Excellent
Return earned on debt + equity capital invested
Optimal:
> 10%
|
13.5%
Good
Good
Return earned on debt + equity capital invested
Optimal:
> 10%
|
— | — |
| Return on Capital (%) (%) |
-8.6%
Weak
Weak
Operating profit relative to total assets
Optimal:
> 10%
|
-7.0%
Weak
Weak
Operating profit relative to total assets
Optimal:
> 10%
|
— | — | — | — | — | — |
| Return on Common Equity (%) (%) |
-21.8%
Weak
Weak
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-246%)
|
-1.8%
Weak
Weak
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-112%)
|
— | — |
26.4%
Excellent
Excellent
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Above avg (+76%)
|
33.8%
Excellent
Excellent
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Above avg (+125%)
|
— | — |
| Metric | Q3 FY2026 Dec 31, 2025 10-Q ↗ | Q2 FY2026 Sep 30, 2025 10-Q ↗ | Q1 FY2026 Jun 30, 2025 10-Q ↗ | Q4 FY2025 Mar 31, 2025 10-Q ↗ | Q3 FY2025 Dec 31, 2024 10-Q ↗ | Q2 FY2025 Sep 30, 2024 10-Q ↗ | Q1 FY2025 Jun 30, 2024 10-Q ↗ | Q4 FY2024 Mar 31, 2024 10-Q ↗ |
|---|---|---|---|---|---|---|---|---|
| Working Capital (USD) | $-1.81M | $-781.05K | — | $-1.03M | — | — | — | — |
| Total Equity (USD) | $13.50M | $16.07M | $-1.33M | $-1.04M | $-1.08M | $-825.80K | $-673.76K | $-490.76K |
| Metric | Q3 FY2026 Dec 31, 2025 10-Q ↗ | Q2 FY2026 Sep 30, 2025 10-Q ↗ | Q1 FY2026 Jun 30, 2025 10-Q ↗ | Q4 FY2025 Mar 31, 2025 10-Q ↗ | Q3 FY2025 Dec 31, 2024 10-Q ↗ | Q2 FY2025 Sep 30, 2024 10-Q ↗ | Q1 FY2025 Jun 30, 2024 10-Q ↗ | Q4 FY2024 Mar 31, 2024 10-Q ↗ |
|---|---|---|---|---|---|---|---|---|
| Sales/Revenue/Turnover (USD) | $1.53M | $2.13M | — | — | $1.24K | $2.03K | — | — |
| Net Income, GAAP (USD) | $-2.95M | $-295.07K | — | — | $-285.07K | $-278.83K | — | — |
| Operating Cash Flow (USD) | $-766.27K | — | — | — | $-57.07K | — | — | — |
Secondary lens
Benchmark Lens
Compare ADTI against peers after checking the statement evidence.
Open lens
Benchmark Lens
Compare ADTI against peers after checking the statement evidence.
Compare ADTI with peers
Stack ADTI against similar companies across every metric on this page.
north_east Open comparisonbar_chart Data from SEC EDGAR XBRL filings
Synced 1 week ago